Literature DB >> 14504423

Current attitudes to the therapy of vasculitis.

David Jayne1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504423     DOI: 10.1159/000072990

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


× No keyword cloud information.
  5 in total

1.  Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.

Authors:  H Timlin; S M Lee; R L Manno; P Seo; Duvura Geetha
Journal:  Semin Arthritis Rheum       Date:  2015-02-20       Impact factor: 5.532

2.  Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis.

Authors:  Maëlis Kauffmann; Mickaël Bobot; Thomas Robert; Stéphane Burtey; Grégoire Couvrat-Desvergnes; Frédéric Lavainne; Xavier Puéchal; Benjamin Terrier; Thomas Quéméneur; Stanislas Faguer; Alexandre Karras; Philippe Brunet; Cécile Couchoud; Noémie Jourde-Chiche
Journal:  Clin J Am Soc Nephrol       Date:  2021-11       Impact factor: 8.237

Review 3.  Management of acute renal failure in the elderly patient: a clinician's guide.

Authors:  Ching M Cheung; Arvind Ponnusamy; John G Anderton
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Vasculitis treatment - new therapeutic approaches.

Authors:  Michael J Dillon
Journal:  Eur J Pediatr       Date:  2006-03-09       Impact factor: 3.183

Review 5.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.